Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Arecor Therape (AREC) Share Price

Price 38.00p on 18-04-2025 at 04:45:07
Change 0.00p 0%
Buy 40.00p
Sell 36.00p
Buy / Sell AREC Shares
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 335.00 at 39.40p
Day's Volume: 0
Last Close: 38.00p
Open: 0.00p
ISIN: GB00BMWLM973
Day's Range 0.00p - 0.00p
52wk Range: 37.50p - 170.00p
Market Capitalisation: £14m
VWAP: 0.00p
Shares in Issue: 38m

Sector: Medicine and Biotech

Listed In: FTSE AIM All-Share,

Arecor Therape (AREC) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 335 39.40p Ordinary
 10:57:49 - 17-Apr-25
Unknown* 88,956 36.00p Negotiated Trade
 16:04:19 - 16-Apr-25
Unknown* 64,922 38.50p Negotiated Trade
 15:58:31 - 16-Apr-25
Unknown* 64,922 38.50p Negotiated Trade
 15:57:56 - 16-Apr-25
Unknown* 64,922 38.50p Negotiated Trade
 15:57:20 - 16-Apr-25
Buy* 145 40.00p SI Trade
 08:03:22 - 16-Apr-25
Sell* 2 36.00p SI Trade
 08:03:22 - 16-Apr-25
Buy* 100 40.00p SI Trade
 08:03:22 - 16-Apr-25
Unknown* 28,223 36.00p Ordinary
 11:11:54 - 15-Apr-25
Unknown* 28,223 36.10p Ordinary
 11:11:14 - 15-Apr-25
See more Arecor Therape trades

Arecor Therape (AREC) Share Price History

Time period:
to
Date Open High Low Close Volume
18th Apr 2025 (Fri) 38.00 38.00 38.00 38.00 0
17th Apr 2025 (Thu) 38.00 38.00 38.00 38.00 335
16th Apr 2025 (Wed) 38.00 38.00 38.00 38.00 1,823
15th Apr 2025 (Tue) 38.00 38.00 38.00 38.00 56,446
14th Apr 2025 (Mon) 38.00 38.00 38.00 38.00 0
11th Apr 2025 (Fri) 38.00 38.00 38.00 38.00 0
10th Apr 2025 (Thu) 38.00 38.00 38.00 38.00 14,311
9th Apr 2025 (Wed) 38.00 39.00 38.00 38.00 2,660
8th Apr 2025 (Tue) 38.00 38.00 38.00 38.00 11,126
7th Apr 2025 (Mon) 38.00 38.00 38.00 38.00 2,535
4th Apr 2025 (Fri) 41.50 41.50 37.50 38.00 7,153
3rd Apr 2025 (Thu) 41.50 41.50 41.50 41.50 70,956
2nd Apr 2025 (Wed) 41.80 42.50 41.20 42.50 18,255
1st Apr 2025 (Tue) 43.50 43.50 42.50 42.50 1
31st Mar 2025 (Mon) 43.50 43.50 43.50 43.50 99,063
28th Mar 2025 (Fri) 48.00 48.00 43.50 43.50 49,002
27th Mar 2025 (Thu) 48.00 48.00 48.00 48.00 25,790
26th Mar 2025 (Wed) 51.50 51.50 48.00 48.00 53,879
25th Mar 2025 (Tue) 49.00 49.00 49.00 49.00 4,281
24th Mar 2025 (Mon) 49.00 49.00 49.00 49.00 2,882
21st Mar 2025 (Fri) 49.00 49.00 49.00 49.00 0
20th Mar 2025 (Thu) 49.00 49.00 49.00 49.00 123
19th Mar 2025 (Wed) 49.50 49.50 49.00 49.00 11
See more Arecor Therape price history

Arecor Therape (AREC) Regulatory News

Date Source Headline
10th Apr 2025 7:00 am RNS Notice of Results
26th Mar 2025 7:00 am RNS Collaboration with global pharmaceutical partner
12th Mar 2025 7:00 am RNS Arecor partnership with biopharmaceutical company
3rd Feb 2025 7:00 am RNS Arecor Full Year 2024 Trading Update
10th Jan 2025 7:45 am RNS Orderly Cessation of Tetris Pharma Operations
9th Jan 2025 7:00 am RNS Change of Nominated Advisor and Joint Broker
30th Dec 2024 7:00 am RNS Arecor Signs Exclusive Licensing Agreement
2nd Dec 2024 7:00 am RNS Grant of Options and PDMR Dealing
18th Nov 2024 7:00 am RNS Arecor Appoints Interim Chief Financial Officer
26th Sep 2024 7:00 am RNS Interim Results for six months ended 30 June 2024
See more Arecor Therape regulatory news

Arecor Therape (AREC) Share News

UK earnings, trading statements calendar - next 7 days

15th Apr 2025 14:20

Read More

Arecor Therapeutics strikes deal for development of peptide therapy

12th Mar 2025 15:34

(Alliance News) - Arecor Therapeutics PLC on Wednesday said it has partnered with an unnamed biopharmaceutical company to develop a novel formulation of peptide therapy. Read More

Arecor Therapeutics confident for the future as revenue rises

3rd Feb 2025 13:28

(Alliance News) - Arecor Therapeutics PLC on Monday said its revenue increased in 2024 and said it is excited by the prospects of its "superior insulin candidate". Read More

IN BRIEF: Arecor Therapeutics shares tumble as plans Tetris wind-down

10th Jan 2025 21:21

Arecor Therapeutics PLC - Cambridgeshire, England-based biopharmaceutical company - Announces the orderly cessation of operations within the Tetris Pharma subsidiary, and a mutual agreement with Xeris BioPharma Holdings Inc to return the group's rights to medication Ogluo. Forms part of the group's strategic review. This concludes that rising supply chain costs and fixed selling prices have significantly reduced margins for Ogluo. In addition, the 2025 revenue outlook for non-Ogluo sales has been materially reduced in light of a partner losing a key NHS tender, materially reducing 2025 revenues for non-Ogluo products. The strategic decision to cease Tetris Pharma operations will enable the group to focus its efforts and resources on opportunities that offer "higher potential for value creation." Read More

IN BRIEF: Arecor Therapeutics signs new drug licensing agreement

30th Dec 2024 11:44

Arecor Therapeutics PLC - Cambridgeshire, England-based biopharmaceutical company - Signs licensing agreement for its AT351 liquid drug product with "a wholly owned subsidiary of one of the world's largest independent chemicals marketing companies". Arecor says it receives an undisclosed upfront payment and is eligible for development, regulatory, and commercial milestone payments and royalties on global sales. The licensee receives an exclusive worldwide license and is responsible for all development, regulatory and commercialisation activities. The licensee will pursue approval from the US Food & Drug Administration, with filing expected within three years. Read More

See more Arecor Therape news
FTSE 100 Latest
Value8,275.66
Change0.00

Login to your account

Forgot Password?

Not Registered